STOCK TITAN

Palisade Bio: Ameriprise reports 8.4% ownership

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Palisade Bio, Inc. (PALI) is the subject of an amended beneficial-ownership report from Ameriprise Financial, Columbia Management Investment Advisers, and Seligman Healthcare Spectrum (Master) Fund. As of September 30, 2026, the Fund reported beneficial ownership of 11,988,235 shares, or 6.9%. The adviser and parent each reported beneficial ownership of 14,567,993 shares, or 8.4%.

The reported amounts overlap: the adviser’s amount includes the Fund’s shares, and Ameriprise’s includes the adviser’s. Columbia Management Investment Advisers and Ameriprise state they do not directly own the shares and disclaim beneficial ownership.

Fund beneficial ownership 11,988,235 shares; 6.9% Seligman Healthcare Spectrum (Master) Fund, as of September 30, 2026
Adviser beneficial ownership 14,567,993 shares; 8.4% Columbia Management Investment Advisers, as of September 30, 2026; includes the Fund’s reported shares
Parent beneficial ownership 14,567,993 shares; 8.4% Ameriprise Financial, as of September 30, 2026; includes the adviser’s reported shares
beneficial ownership regulatory
"Amount beneficially owned"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared voting power regulatory
"Shared Voting Power 14,567,993.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared Dispositive Power 14,567,993.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Palisade Bio (PALI) shares did the reporting parties report?

As of September 30, 2026, Seligman Healthcare Spectrum (Master) Fund reported 11,988,235 shares, or 6.9%, while Columbia Management Investment Advisers and Ameriprise Financial each reported 14,567,993 shares, or 8.4%. The adviser’s amount includes the Fund’s reported shares, and the parent’s amount includes the adviser’s, so the amounts overlap.

What voting and dispositive powers did the PALI reporting parties report?

The Fund reported sole voting power over 11,988,235 shares and shared dispositive power over the same number. Columbia Management Investment Advisers and Ameriprise Financial each reported shared voting and shared dispositive power over 14,567,993 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





696389402

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Ameriprise Financial, Inc.
Signature:/s/ Michael G. Clarke
Name/Title:Michael G. Clarke, Senior Vice President, North America Head of Operations & Investor Services
Date:11/16/2026
Columbia Management Investment Advisers, LLC
Signature:/s/ Michael G. Clarke
Name/Title:Michael G. Clarke, Senior Vice President, North America Head of Operations & Investor Services
Date:11/16/2026
Seligman Healthcare Spectrum (Master) Fund
Signature:/s/ Michael G. Clarke
Name/Title:Michael G. Clarke, Authorized Person
Date:11/16/2026

Comments accompanying signature: Contact Information Charles Chiesa VP Fund Treasurer Global Operations and Investor Services Telephone: 617-385-9593
Exhibit Information

Exhibit Index Exhibit I Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company. Exhibit II Joint Filing Agreement

Keep reading